The Board of Directors of Raaj Medisafe India Limited ('the Company') at its meeting held today, i.e., 26th March, 2026, approved the allotment of 32,75,000 fully paid-up equity shares ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Raaj Medisafe India Ltd's board, at its meeting on 26th March 2026, approved the allotment of 32,75,000 fully paid-up equity shares of face value Rs. 10 each at Rs. 55 per share (including a Rs. 45 premium). This is a preferential issue to 16 non-promoter allottees for cash consideration, raising approximately Rs. 18.01 crore. All allottees currently hold no shares (except Kul Anand with 100 shares), and post-issue, their collective holding will be around 19.94% of the company. The company had received in-principle approval from BSE on 12th March 2026 and will now apply for listing approval. The new shares will rank pari-passu with existing equity shares.
The preferential allotment at Rs. 55 (a Rs. 45 premium over face value) brings in roughly Rs. 18 crore from new non-promoter shareholders who will collectively hold nearly 20% post-issue. This dilutes existing shareholders' stakes and may put short-term pressure on the stock price, though the funds raised could support growth if deployed productively.